Cite

HARVARD Citation

    Maillart, E. et al. (2020). Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder. Neurology. 7 (3), p. . [Online]. 
  
Back to record